Roth MKM Reiterates Buy on Phibro Animal Health, Maintains $21 Price Target
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Brian Wright has reiterated a 'Buy' rating on Phibro Animal Health (NASDAQ:PAHC), maintaining a price target of $21.
September 01, 2023 | 3:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phibro Animal Health's stock rating has been reiterated as 'Buy' by Roth MKM with a maintained price target of $21.
The reiteration of a 'Buy' rating by a reputable analyst like Brian Wright from Roth MKM is a positive signal for investors. The maintained price target of $21 indicates that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100